🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

we are excited to share our latest work on mapping and exploiting conditional drug sensitivity in cancer cells Science Advances! next chapter of unbiased profiling in #HPLM as a source of new insights! congrats to co-1st Kyle Flickinger and Kelli Wilson! science.org/doi/10.1126/sc…

New! Online now: Quantification of nutrient fluxes during acute exercise in mice dlvr.it/TFMr8Y

I'm almost to my goal to raise funds toward innovative cancer research! Click the link to donate! pelotonia.org/profile/EV0033

Great to see the preprint from Owen Sansom 🏳️‍🌈 published in Cancer Research KRAS Loss of Heterozygosity Promotes MAPK-Dependent #PancreaticCancer Initiation and Induces Therapeutic Sensitivity to MEK Inhibition aacrjournals.org/cancerres/arti… In the KRAS inhibitor era, these findings on the wild

Watch Dr. Hsiu-Chiung Yang discuss her poster session siRNA-INHBE Silencing in Mice Confirms Human Genetic Data and Supports a New Approach for Obesity at #OW2024. Comment below on what you want to learn from this session!

Excited to share the first research publication from our lab! Lipid availability influences ferroptosis sensitivity in cancer cells by regulating polyunsaturated fatty acid trafficking sciencedirect.com/science/articl…

Ty so much Zobeida Cruz-Monserrate Ph.D. 🇵🇷 and members! Still can't believe it!

A very special day! Officially Phinished! Ty Zobeida Cruz-Monserrate Ph.D. 🇵🇷 The Ohio State University Wexner Medical Center

We’re thrilled to announce the launch of Center for RAS Therapeutics to target the RAS oncogene in cancer. The first of its kind Center aims to advance new treatment approaches for patients with RAS mutant cancers. Learn more: bit.ly/3BobmtB

A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites: Cell cell.com/cell/fulltext/…

🧵1/ Excited to share our latest review on how organoid technology is transforming pancreatic cancer research, published in Experimental & Molecular Medicine. Here's a breakdown of the key points. nature.com/articles/s1227…

Brain-gut-pancreas axis uncovered! 🧠➡️💡| Science Magazine Neuron-activated #ILC2s migrate from the gut to the pancreas, driving glucagon production through cytokine signaling. A groundbreaking link between #neuroimmune pathways & glucose regulation! science.org/doi/10.1126/sc…

Ecstatic to see this out! Important implications for immune targeting in pancreatic cancer. Has been a labour of love! Lots of fantastic collaborators and important new early phase trials being set up! nature.com/articles/s4146…

NEW STUDY: Intermittent fasting (IF) significantly alters the microbiome of mice, with reductions in the gut production of obeticholic acid, a bile acid that induces expression of gut-derived hormones, and an increase in N-acetylglycine production Why is this interesting? 🧵

Sad to learn that the #PancreaticCancer research program (PCARP) will receive no funds in the current FY. 😢 I served as program review chair for 3y & we really tried to fund areas that are of pivotal importance to patients (like cancer cachexia research) but underfunded at NCI.

Heard the news a couple of days ago and I’m still processing it all. The MARC/RISE programs allowed me to do research in undergrad in #PR UPR Río Piedras and introduced me to what will be my upcoming career. Without it I don’t think I would’ve taken the path that I did. This is just sad.

Join us for #DataoverDinner on May 22, 2025 6-8pm at the Pelotonia Headquarters - Community Space at OSU. Insightful talks over dinner & play the raffle for chance to win giftcards! Zobeida Cruz-Monserrate Ph.D. 🇵🇷 Pelotonia The Ohio State University Wexner Medical Center @OSU The James ouab #Pelotonia #Fundraising #CancerResearch

Come join Zobeida Cruz-Monserrate Ph.D. 🇵🇷 for some fundraising fun with Team Buckeye Guts in Gear Peloton! Pelotonia

Amazing time at our Data Over Dinner event #Fundraising for #Pelotonia with Zobeida Cruz-Monserrate Ph.D. 🇵🇷 and Maria Mihaylova lab. The Ohio State University Wexner Medical Center The James